Literature DB >> 25583621

Early detection of pulmonary arterial hypertension: do not forget the right ventricle.

Gaetano Ruocco1, Alberto Palazzuoli1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25583621     DOI： 10.1038/nrcardio.2014.191-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

3.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

Authors:  Norbert F Voelkel; Robert A Quaife; Leslie A Leinwand; Robyn J Barst; Michael D McGoon; Daniel R Meldrum; Jocelyn Dupuis; Carlin S Long; Lewis J Rubin; Frank W Smart; Yuichiro J Suzuki; Mark Gladwin; Elizabeth M Denholm; Dorothy B Gail
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

Review 4.  Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications.

Authors:  Hunter C Champion; Evangelos D Michelakis; Paul M Hassoun
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

Review 5.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

Review 7.  Pulmonary arterial hypertension: the key role of echocardiography.

Authors:  Eduardo Bossone; Bruno Dino Bodini; Alfredo Mazza; Luigi Allegra
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

Review 8.  Early detection of pulmonary arterial hypertension.

Authors:  Edmund M T Lau; Marc Humbert; David S Celermajer
Journal:  Nat Rev Cardiol       Date:  2014-11-25       Impact factor: 32.419

Review 9.  Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?

Authors:  Anton Vonk-Noordegraaf; Rogério Souza
Journal:  Am J Cardiol       Date:  2012-09-15       Impact factor: 2.778

Review 10.  Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension.

Authors:  L E R McLure; A J Peacock
Journal:  Eur Respir J       Date:  2009-06       Impact factor: 16.671
  10 in total
  1 in total

Review 1.  Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF.

Authors:  Maria Barilli; Maria Cristina Tavera; Serafina Valente; Alberto Palazzuoli
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.